![]() |
|
|
Department of Medical Pharmacology and Physiology, Dalton Cardiovascular Research Center, University of Missouri-Columbia School of Medicine, Columbia, Missouri
To examine the effects of capsaicin on cystic fibrosis transmembrane conductance regulator (CFTR), we recorded wild-type and mutant CFTR chloride-channel currents using patch-clamp methods. The effects of capsaicin were compared with those of genistein, a well-characterized CFTR activator. In whole-cell experiments, capsaicin potentiates cAMP-stimulated wild-type CFTR currents expressed in NIH 3T3 cells or Chinese hamster ovary cells in a dose-dependent manner with a maximal response
60% of that with genistein and an apparent Kd of 48.4 ± 6.8 µM. In cell-attached recordings, capsaicin alone fails to activate CFTR in cells that show negligible basal CFTR activity, indicating that capsaicin does not stimulate the cAMP cascade. The magnitude of potentiation with capsaicin depends on the channel activity before drug application; the lower the prestimulated Po, the higher the potentiation. Single-channel kinetic analysis shows that capsaicin potentiates CFTR by increasing the opening rate and decreasing the closing rate of the channel. Capsaicin may act as a partial agonist of genistein because the maximally enhanced wild-type CFTR currents with genistein are partially inhibited by capsaicin. Capsaicin increases
R-CFTR, a protein kinase A (PKA)-independent, constitutively active channel, in cell-attached patches. In excised inside-out patches, capsaicin potentiates the PKA-phosphorylated, ATP-dependent CFTR activity. Both capsaicin and genistein potentiate the cAMP-stimulated G551D-CFTR,
F508-CFTR, and 8SA mutant channel currents. The binding site for capsaicin is probably located at the cytoplasmic domain of CFTR, because pipette application of capsaicin fails to potentiate CFTR activity. In conclusion, capsaicin is a partial agonist of genistein in activation of the CFTR chloride channel. Both compounds affect ATP-dependent gating of CFTR.
Address correspondence to: Dr. Tzyh-Chang Hwang, Department of Medical Pharmacology and Physiology, Dalton Cardiovascular Research Center, University of Missouri-Columbia School of Medicine, 134 Research Park, Columbia, MO 65211. E-mail: hwangt{at}health.missouri.edu
This article has been cited by other articles:
![]() |
S. G. Bompadre, M. Li, and T.-C. Hwang Mechanism of G551D-CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Potentiation by a High Affinity ATP Analog J. Biol. Chem., February 29, 2008; 283(9): 5364 - 5369. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Scott-Ward, Z. Cai, E. S. Dawson, A. Doherty, A. Carina Da Paula, H. Davidson, D. J. Porteous, B. J. Wainwright, M. D. Amaral, D. N. Sheppard, et al. Chimeric constructs endow the human CFTR Cl channel with the gating behavior of murine CFTR PNAS, October 9, 2007; 104(41): 16365 - 16370. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Bompadre, Y. Sohma, M. Li, and T.-C. Hwang G551D and G1349D, Two CF-associated Mutations in the Signature Sequences of CFTR, Exhibit Distinct Gating Defects J. Gen. Physiol., March 26, 2007; 129(4): 285 - 298. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Zegarra-Moran, M. Monteverde, L. J. V. Galietta, and O. Moran Functional Analysis of Mutations in the Putative Binding Site for Cystic Fibrosis Transmembrane Conductance Regulator Potentiators: INTERACTION BETWEEN ACTIVATION AND INHIBITION J. Biol. Chem., March 23, 2007; 282(12): 9098 - 9104. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Artigas, S. J. Al'Aref, E. A. Hobart, L. F. Diaz, M. Sakaguchi, S. Straw, and O. S. Andersen 2,3-Butanedione Monoxime Affects Cystic Fibrosis Transmembrane Conductance Regulator Channel Function through Phosphorylation-Dependent and Phosphorylation-Independent Mechanisms: The Role of Bilayer Material Properties Mol. Pharmacol., December 1, 2006; 70(6): 2015 - 2026. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cai, A. Taddei, and D. N. Sheppard Differential Sensitivity of the Cystic Fibrosis (CF)-associated Mutants G551D and G1349D to Potentiators of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl- Channel J. Biol. Chem., January 27, 2006; 281(4): 1970 - 1977. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhou, X. Wang, M. Li, Y. Sohma, X. Zou, and T.-C. Hwang High affinity ATP/ADP analogues as new tools for studying CFTR gating J. Physiol., December 1, 2005; 569(2): 447 - 457. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lundbaek, P. Birn, S. E. Tape, G. E. S. Toombes, R. Sogaard, R. E. Koeppe II, S. M. Gruner, A. J. Hansen, and O. S. Andersen Capsaicin Regulates Voltage-Dependent Sodium Channels by Altering Lipid Bilayer Elasticity Mol. Pharmacol., September 1, 2005; 68(3): 680 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schnizler, B. Saeger, C. Pfeffer, A. Gerbaulet, U. Ebbinghaus-Kintscher, C. Methfessel, E.-M. Franken, K. Raming, C. H. Wetzel, A. Saras, et al. A Novel Chloride Channel in Drosophila melanogaster Is Inhibited by Protons J. Biol. Chem., April 22, 2005; 280(16): 16254 - 16262. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Bompadre, T. Ai, J. H. Cho, X. Wang, Y. Sohma, M. Li, and T.-C. Hwang CFTR Gating I: Characterization of the ATP-dependent Gating of a Phosphorylation-independent CFTR Channel ({Delta}R-CFTR) J. Gen. Physiol., March 28, 2005; 125(4): 361 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Bompadre, J. H. Cho, X. Wang, X. Zou, Y. Sohma, M. Li, and T.-C. Hwang CFTR Gating II: Effects of Nucleotide Binding on the Stability of Open States J. Gen. Physiol., March 28, 2005; 125(4): 377 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Berger, C. O. Randak, L. S. Ostedgaard, P. H. Karp, D. W. Vermeer, and M. J. Welsh Curcumin Stimulates Cystic Fibrosis Transmembrane Conductance Regulator Cl- Channel Activity J. Biol. Chem., February 18, 2005; 280(7): 5221 - 5226. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N. Sheppard CFTR Channel Pharmacology: Novel Pore Blockers Identified by High-throughput Screening J. Gen. Physiol., July 26, 2004; 124(2): 109 - 113. [Full Text] [PDF] |
||||